Vinay Chandramouli Bellur | Surgical Oncology | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Best Researcher Award

Vinay Chandramouli Bellur – Ramaiah Medical College, India

Vinay Chandramouli Bellur 
Affiliation Ramaiah Medical College
Country India
Scopus ID 60215263800
Documents 3
Citations 594
h-index 1
Subject Area Surgical Oncology
Event World Top Scientists Awards
ORCID View Profile

Vinay Chandramouli Bellur is a medical researcher affiliated with Ramaiah Medical College whose documented scholarly activity spans internal medicine, cardiology, oncology, gastroenterology, and related clinical research areas. The supplied Google Scholar record includes systematic reviews, meta-analyses, clinical outcome investigations, and conference publications. His recent research involvement includes cardiovascular interventions, gastrointestinal disorders, cancer research, neurological treatment, and artificial intelligence applications in medicine.[1]

Abstract

The research profile of Vinay Chandramouli Bellur reflects multidisciplinary participation in contemporary medical research, particularly through evidence synthesis and collaborative clinical investigations. The available record includes work related to cardiovascular disease, gastrointestinal medicine, oncology, neurology, and artificial intelligence. Several listed studies use systematic review and meta-analysis methodology to evaluate clinical evidence across specific diagnostic, therapeutic, and outcome-related questions.[1]

Keywords

Surgical Oncology; Clinical Research; Systematic Review; Meta-analysis; Cardiology; Gastroenterology; Oncology; Artificial Intelligence; Medical Imaging; Evidence Synthesis

Introduction

Bellur’s documented research activities demonstrate involvement in multiple areas of clinical and translational medicine. The supplied publication record contains studies addressing interventional cardiology, esophageal surgery, liver disease, neurological treatment, cancer therapeutics, and diagnostic applications of artificial intelligence. This range is particularly relevant to modern clinical research because systematic evidence assessment can connect findings from different specialties and help identify areas requiring additional investigation.[2]

Research Profile

The supplied researcher information identifies Ramaiah Medical College as Bellur’s affiliation and Surgical Oncology as the stated subject area. The Google Scholar document describes him as a medical student and lists research interests encompassing internal medicine, cardiology, oncology, and gastroenterology.[1] The supplied award data records three documents, 594 citations, and an h-index of 1, while the Google Scholar snapshot captured on 21 September 2026 displays 584 citations and an h-index of 1. These database figures can vary according to indexing and update timing.

Research Contributions

A central component of the documented work is systematic evidence synthesis. Bellur is listed among the authors of research examining intraoperative nerve monitoring during esophagectomy, with the study using systematic review and meta-analysis methodology.[5] Other contributions address IVUS-guided versus angiography-guided PCI, artificial intelligence for liver fibrosis diagnosis, and MRI-based radiomics for predicting molecular characteristics of glioblastoma. These studies connect clinical medicine with quantitative evidence evaluation and emerging diagnostic technologies.[2][3][4]

Publications

The available publication record contains articles and conference abstracts published across several established medical journals. Listed works include research in the Journal of the American College of Cardiology, Gastrointestinal Endoscopy, Journal of Clinical Oncology, Neurology, and Journal of Gastrointestinal Surgery Open.[1] The topics range from cardiovascular interventions and perioperative monitoring to gastrointestinal disease, cancer outcomes, neurological treatment, and computational diagnostic methods. This publication distribution illustrates participation in collaborative research addressing diverse clinical questions.

Research Impact

Citation activity in the supplied Google Scholar record indicates substantial visibility for some collaborative publications. The listed cardiovascular burden study, for example, is displayed with 577 citations in the supplied snapshot, while several other publications from 2025 and 2026 have begun receiving citations.[1] Citation counts should be interpreted in relation to publication date, article type, collaborative authorship, and database coverage. The available evidence therefore provides a quantitative indication of scholarly attention while retaining the limitations inherent to citation-based assessment.

Award Suitability

The documented profile provides several research indicators relevant to an academic recognition article, including indexed publications, citation activity, multidisciplinary collaboration, and participation in systematic reviews and meta-analyses. His listed research also connects conventional clinical investigation with emerging technologies such as artificial intelligence and medical radiomics. These documented activities provide the academic basis for presenting Bellur in connection with the Best Researcher Award at the World Top Scientists Awards. Award evaluation itself remains subject to the criteria and procedures established by the awarding organization.

Conclusion

Vinay Chandramouli Bellur’s available research record represents multidisciplinary clinical scholarship with particular involvement in systematic reviews, meta-analyses, and collaborative medical investigations. His documented topics include cardiovascular medicine, gastrointestinal research, oncology, neurology, surgical outcomes, and artificial intelligence-assisted diagnosis. The combination of recent research activity and established citation visibility provides a substantive scholarly profile for academic recognition. The information presented here is based on the supplied researcher data and Google Scholar publication record.

References

  1. Google Scholar. (2026). Vinay Chandramouli Bellur — Google Scholar profile and publication record.
    https://scholar.google.com/citations?user=4CwA1r0AAAAJ&hl=en
  2. Babu Naidu, K. B., Bellur, V. C., Prasad, A., et al. (2025). TCT-675 Intravascular Ultrasonography (IVUS) Versus Angiography-Guided Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis. Journal of the American College of Cardiology, 86(17_Supplement), B294.
    https://doi.org/10.1016/j.jacc.2025.09.829
  3. Babu Naidu, K. B., Bellur, V. C., Oudit, O., Prasad, A., et al. (2025). S2534 Diagnostic Accuracy of Artificial Intelligence in the Diagnosis of Liver Fibrosis: A Systematic Review and Meta Analysis. The American Journal of Gastroenterology, 120(10S2), S544.
    https://doi.org/10.14309/01.ajg.0001137596.28464.e8
  4. Belankar, S., Bhavanam, S., Prasad, A., Rao, A. N., Chitlur, H., Bellur, V. C., et al. (2025). MRI-based radiomics for prediction of isocitrate dehydrogenase subtype in glioblastoma multiforme through artificial intelligence models: A systematic review and meta analysis. Journal of Clinical Oncology, 43(16_suppl), 2074.
    https://doi.org/10.1200/JCO.2025.43.16_suppl.2074
  5. Rao, A. N., Bellur, V. C., Prasad, A., Karaveetil, S. C., Narayan, S., Raj, A., et al. (2026). Outcomes of Intraoperative Nerve Monitoring During Esophagectomy: A Systematic Review and Meta-Analysis. Journal of Gastrointestinal Surgery Open, 100025.
    https://doi.org/10.1016/j.jogsop.2026.100025

Alissa Groenendijk | Pediatric Oncology | Innovative Research Award

Published on | Editorial Board by World Top Scientists

Innovative Research Award

Alissa Groenendijk
Researcher Alissa Groenendijk
Affiliation Princess Máxima Center for Pediatric Oncology
Country Netherlands
Scopus ID 57224777633
Documents 8
Citations 103
h-index 4
Subject Area Pediatric Oncology
Event World Top Scientist Awards
ORCID 0000-0001-6466-7785

Alissa Groenendijk
Princess Máxima Center for Pediatric Oncology

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate meaningful scientific advancement, methodological rigor, and measurable research influence. Alissa Groenendijk has contributed to the field of pediatric oncology through published research focused on childhood cancer, clinical outcomes, and translational biomedical investigations. Her scholarly profile reflects peer-reviewed publications, citation impact, and engagement with internationally indexed research databases, providing evidence of an active academic career.[1]

Abstract

Alissa Groenendijk’s academic profile illustrates participation in pediatric oncology research emphasizing clinically relevant questions related to childhood malignancies, patient management, and translational science. Her publications indexed in Scopus indicate consistent scientific engagement and measurable citation performance. These indicators support consideration for recognition through research excellence awards that acknowledge scholarly productivity and scientific contribution.[1][2]

Keywords

Innovative Research Award, Alissa Groenendijk, Pediatric Oncology, Childhood Cancer, Wilms Tumor, Translational Medicine, Clinical Oncology, Cancer Research, Molecular Oncology, Pediatric Cancer Research, Princess Máxima Center for Pediatric Oncology, Scientific Research Excellence, Academic Recognition, Scopus Author, ORCID Researcher, Biomedical Research, Oncology Publications, Research Impact, Citation Analysis, World Top Scientist Awards.

Introduction

Research in pediatric oncology requires multidisciplinary collaboration, evidence-based clinical investigation, and continuous improvement in patient outcomes. Scholars working within this discipline contribute to advances in diagnosis, treatment strategies, survivorship, and quality of care. Academic recognition programs evaluate researchers using publication quality, citation metrics, scientific influence, and contributions to knowledge dissemination.[3]

Research Profile

Affiliated with the Princess Máxima Center for Pediatric Oncology in the Netherlands, Alissa Groenendijk has developed an academic portfolio represented through indexed publications and international scholarly visibility. According to the available Scopus profile, her research output comprises eight indexed documents with more than one hundred citations and an h-index of four, reflecting growing academic influence within her specialization.[1]

Research Contributions

Her published work contributes to pediatric oncology by addressing clinically meaningful research questions relevant to childhood cancers and translational medicine. Such investigations assist healthcare professionals and researchers in understanding disease mechanisms, evaluating therapeutic approaches, and supporting evidence-informed clinical practice. The integration of collaborative research strengthens the broader scientific understanding of pediatric cancer management.[2]

Publications

The available publication record demonstrates contributions to peer-reviewed scientific literature indexed within international bibliographic databases. Publications have accumulated citations from subsequent studies, indicating continued scholarly engagement with the reported findings. Many biomedical articles are assigned Digital Object Identifiers (DOIs), enabling persistent identification and long-term accessibility within scholarly communication.[2][4]

Research Impact

Citation counts, h-index values, publication records, and institutional affiliations collectively provide commonly accepted indicators for evaluating research influence. Although bibliometric measures should be interpreted alongside qualitative scientific assessment, they remain valuable tools for recognizing sustained scholarly productivity and academic visibility.[1][3]

Award Suitability

Based on publicly available scholarly indicators, Alissa Groenendijk demonstrates characteristics frequently considered during evaluations for academic recognition, including peer-reviewed publications, measurable citation performance, institutional research affiliation, and contributions to pediatric oncology. Final award determinations remain subject to the eligibility requirements, review procedures, and evaluation criteria established by the World Top Scientist Awards.[5]

Conclusion

The academic profile presented here summarizes the publicly available scholarly information associated with Alissa Groenendijk and highlights research activity within pediatric oncology. The combination of indexed publications, citation metrics, institutional affiliation, and ongoing scientific engagement reflects an active contribution to biomedical research while supporting consideration for professional recognition through competitive academic award programs.[1]

References

  1. Groenendijk, A., Mavinkurve-Groothuis, A. M. C., van Tinteren, H., de Krijger, R. R., Al-Saadi, R., Pritchard-Jones, K., Ramírez-Villar, G. L., Vujanic, G., Melchior, P., Godzinski, J., et al. (2026). Characteristics and outcome of patients with second and subsequent relapse of Wilms tumour: A report from the SIOP Renal Tumour Study Group. EJC Paediatric Oncology.
    https://doi.org/10.1016/j.ejcped.2026.100520
  2. Groenendijk, A., Aronow, B. J., Cost, N., Cajaiba, M., Renfro, L. A., Perlman, E. J., Dyer, L., Smolarek, T. A., Mullen, E. A., Pervaiz, S., et al. (2026). Integrated molecular, genomic, and clinical characterization of pediatric and adolescent translocation renal cell carcinoma: A report from the Children’s Oncology Group. Biomedicines, 14(5), 955.
    https://doi.org/10.3390/biomedicines14050955
  3. Groenendijk, A., van Tinteren, H., de Krijger, R. R., Vujanic, G., Al-Saadi, R., Pritchard-Jones, K., Ramírez-Villar, G. L., Melchior, P., Godzinski, J., Schenk, J.-P., et al. (2025). Outcome of patients with a first relapse after intermediate- or high-risk Wilms tumor, treated according to SIOP WT 2001/UK-IMPORT study: A report from the SIOP Renal Tumour Study Group. Urologic Oncology: Seminars and Original Investigations.
    https://doi.org/10.1016/j.urolonc.2025.05.018
  4. Groenendijk, A., Drost, J., Mavinkurve-Groothuis, A. M. C., van Grotel, M., Janssens, G. O., Littooij, A. S., van der Steeg, A. F. W., van den Heuvel-Eibrink, M. M., Kester, L., & de Krijger, R. R. (2025). Gene expression analysis of (paired) primary and relapsed Wilms tumor samples to unravel the underlying factors driving tumor recurrence. Cancer Medicine.
    https://doi.org/10.1002/cam4.70969
  5. van Belzen, I. A. E. M., van Tuil, M., Badloe, S., Strengman, E., Janse, A., Verwiel, E. T. P., van der Leest, D. F. M., de Vos, S., Baker-Hernandez, J., Groenendijk, A., et al. (2022). Molecular characterization reveals subclasses of 1q gain in intermediate-risk Wilms tumors. bioRxiv (Preprint).
    https://doi.org/10.1101/2022.08.12.503742

Ramadevi Subramani Reddy | Cancer Biology | Research Excellence Award

Published on | Editorial Board by World Top Scientists

Dr. Ramadevi Subramani Reddy | Cancer Biology | Research Excellence Award

Associate Professor | Texas Tech University Health Sciences Center El Paso | United States

Dr. Ramadevi Subramani Reddy is an Associate Professor at Texas Tech University Health Sciences Center El Paso and a researcher in Cancer Biology with extensive expertise in molecular and translational oncology. She holds advanced training in biochemistry and cancer biology, with doctoral specialization in cancer-related cellular mechanisms, including differentiation, cell cycle regulation, and apoptosis. Her professional experience spans progressive research roles from competitive fellowships to senior research and faculty positions, demonstrating sustained leadership in funded cancer research programs. Her work focuses on molecular signaling pathways, inflammation-mediated cancer progression, and translational strategies for cancer prevention and therapy, resulting in a strong body of peer-reviewed publications with significant citation impact. Dr Reddy has contributed to multidisciplinary research initiatives, mentored trainees, and supported collaborative cancer research efforts. Her career is distinguished by nationally and internationally funded fellowships and research awards that recognize her scientific rigor, consistency, and impact in advancing cancer biology research.

Citation Metrics (Google Scholar)

1732
1200
600
300
0

1732

34

24

Citations

Documents

h-index

Krzysztof Jeziorski | Oncology | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Krzysztof Jeziorski | Oncology | Best Researcher Award 

Department of Gerontology and Public Health at National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland

Dr. Krzysztof Grzegorz Jeziorski, MD, PhD, is a distinguished Polish oncologist with a career spanning over four decades in clinical and academic medicine. He has served as Associate Professor and Senior Assistant at the Maria Skłodowska-Curie National Research Cancer Institute in Warsaw since 1988 and continues to contribute as a Clinical Trials Consultant at the National Institute of Geriatrics, Rheumatology and Rehabilitation. Dr. Jeziorski’s professional path is marked by leadership in gastrointestinal cancer research, extensive clinical trial involvement, and international academic collaborations. A former Dean of the Faculty of Health Sciences and Social Sciences, he combines deep clinical expertise with academic excellence. He has participated in fellowships across Europe, including at the University of Oxford and the University of Padova. Renowned for his commitment to advancing cancer research, he continues to enhance his knowledge through postgraduate studies and remains actively engaged in both practice and education.

Professional Profile 

Scopus Profile
ORCID Profile 

Education

Dr. Jeziorski earned his medical degree from the Medical University of Warsaw, completing the I Medical Faculty. He later pursued advanced specialization, obtaining first and second-grade specialties in General Medicine and Chemotherapy of Cancer from the Medical Centre of Postgraduate Education. His passion for oncology led him to further achieve a specialty in Clinical Oncology and a Doctorate in Medical Sciences. In 2009, he was awarded the prestigious Habilitation degree from the Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology. Dr. Jeziorski has continually enriched his education through prestigious fellowships and academic programs, including at the Universities of Oxford, Padova, Brussels, and Cambridge. He completed several key international training programs in epidemiology and public health. Recently, he completed postgraduate studies in Clinical Trial Methodology and is currently pursuing an MBA in Clinical Research and Biomedical Innovation Management at the Medical University of Warsaw, demonstrating his continued commitment to academic and professional growth.

Experience

Dr. Jeziorski brings a wealth of experience from clinical, academic, and administrative roles. Since 1988, he has been a leading figure at the Maria Skłodowska-Curie National Research Cancer Institute in Warsaw, serving as Associate Professor and senior assistant in the Outpatient Department for GI Cancers. He has also been a Clinical Trials Consultant at the National Institute of Geriatrics, Rheumatology and Rehabilitation since 2015. Earlier in his career, he worked with institutions like the Polish Academy of Sciences and served as Dean at the State Higher School of Pope John Paul II in Biała Podlaska. His clinical foundation was established at the Central Hospital of the Medical Academy in Warsaw. Dr. Jeziorski has managed over 20 international clinical trials as a Principal Investigator, contributing significantly to cancer research. His experience integrates scientific leadership, teaching, and hands-on patient care, making him a well-rounded and respected professional in medical oncology and research.

Awards and Honors

While a detailed list of awards is not provided in the curriculum vitae, Dr. Jeziorski’s academic journey includes several significant milestones that reflect a career of distinction. He received his Second Grade Specialty in Chemotherapy of Cancer with distinction, signaling outstanding academic and clinical performance. His international fellowships at elite institutions such as the University of Oxford, University of Padova, and University of Cambridge were awarded on a competitive basis and recognize his academic merit and research potential. Additionally, his long-term appointments at top-tier research institutes and his role as a Dean suggest institutional recognition of his expertise and leadership. Acceptance into high-profile postgraduate and international research training programs—including the Erasmus Summer Program and WHO/IDF seminars—further highlight his professional standing. His ongoing pursuit of an MBA in Clinical Research reflects both personal ambition and recognition of his evolving role in biomedical innovation and management.

Research Focus on Oncology

Dr. Jeziorski’s primary research focus lies in the field of gastrointestinal oncology, where he has made sustained contributions through clinical trials and academic leadership. He has acted as Principal Investigator in over 20 international clinical trials and participated in numerous additional studies as a Sub-Investigator. His research emphasizes improving therapeutic strategies for gastrointestinal neoplasms, with a strong interest in translating scientific findings into clinical practice. Dr. Jeziorski combines rigorous methodological training with deep clinical insight, as demonstrated by his postgraduate studies in clinical trial methodology and his continued education in research management. His international fellowships enriched his approach to evidence-based medicine and interdisciplinary collaboration. Throughout his career, he has actively worked to integrate public health perspectives and epidemiology into oncology research. By maintaining roles in both clinical care and research, Dr. Jeziorski ensures his work remains patient-centered, innovative, and aligned with global advances in cancer treatment.

Publications Top Notes

  • Title: Artificial Intelligence in Oncology

    • Authors: Krzysztof Jeziorski, Robert Olszewski

    • Year: 2024

  • Title: Lost in Communication: Do Family Physicians Provide Patients with Information on Preventing Diet-Related Diseases?

    • Authors: Robert Olszewski, Justyna Obiała, Karolina Obiała, Jakub Owoc, Małgorzata Mańczak, Klaudia Ćwiklińska, Magdalena Jabłońska, Paweł Zegarow, Jolanta Grygielska, Marzena Jaciubek, et al.

    • Year: 2022

  • Title: Hyperthermia in Rheumatic Diseases. A Promising Approach?

    • Author: Krzysztof Jeziorski

    • Year: 2018

  • Title: HER2 Status in GI Adenocarcinoma (TRIO-013/LOGiC Trial)

    • Authors: Press M.F., Ellis C.E., Gagnon R.C., Jeziorski K., et al.

    • Year: 2017

  • Title: Preservation of Duodenal Passage and Quality of Life After Gastrectomy

    • Authors: Olesiński T., Szpakowski M., Saramak P., Rutkowski A., Jeziorski K.

    • Year: 2017

  • Title: Rheumatic and Oncological Diseases – Common Challenges

    • Author: Krzysztof Jeziorski

    • Year: 2017

  • Title: Lapatinib + Chemotherapy in HER2+ GI Cancers (LOGiC Trial)

    • Authors: Hecht J.R., Bang Y.-J., Qin S.K., Jeziorski K., et al.

    • Year: 2016

  • Title: Preoperative Chemoradiation vs Short-Course Therapy in Rectal Cancer

    • Authors: Bujko K., Wyrwicz L., Rutkowski A., Jeziorski K., et al.

    • Year: 2016

  • Title: Validation of QLQ-GINET21 for GI Neuroendocrine Tumors

    • Authors: Yadegarfar G., Friend L., Jeziorski K., et al.

    • Year: 2013

  • Title: Efficacy of Y-90 DOTATATE in GEP-NETs – Phase II Study

    • Authors: Cwikla J.B., Sankowski A., Jeziorski K.G., et al.

    • Year: 2009

  • Title: Radiological Efficacy of 90Y-DOTATATE in Midgut NETs

    • Authors: Cwikla J.B., Sankowski A., Jeziorski K.G., et al.

    • Year: 2009

  • Title: Abscesses After Splenectomy in Gastric/Cardia Cancer Surgery

    • Authors: Szpakowski M., Olesiński T., Jeziorski K., et al.

    • Year: 2007

  • Title: Chemotherapy for Hepatocellular and Biliary Duct Cancers

    • Author: Krzysztof Jeziorski

    • Year: 2007

  • Title: Imaging of Gastroenteropancreatic NETs – Polish Center Experience

    • Authors: Cwikla J.B., Nasierowska-Guttmejer A., Jeziorski K.G., et al.

    • Year: 2007

  • Title: Leptomeningeal Metastases of EGJ Adenocarcinoma – Case Report

    • Authors: Olesiński T., Jeziorski K., Szawłowski A.

    • Year: 2007

Conclusion

Dr. Krzysztof Jeziorski exemplifies a distinguished researcher and clinician whose contributions to gastrointestinal oncology span over four decades. His involvement in high-impact, multi-center clinical trials, coupled with authorship in internationally recognized journals such as Journal of Clinical Oncology, Annals of Oncology, and British Journal of Cancer, highlights both the breadth and relevance of his work. He has consistently collaborated with global experts and participated in pivotal studies that influence cancer treatment protocols. His recent engagement with artificial intelligence in oncology indicates a forward-thinking and adaptive research approach. Although citation metrics for many of his publications are not readily available, the scope, continuity, and quality of his work speak to his lasting impact on cancer research. Dr. Jeziorski’s blend of clinical excellence, academic leadership, and international collaboration positions him as a highly deserving candidate for the Best Researcher Award, with a legacy that bridges science, innovation, and patient-centered care.